Sign in

CIK 0001681087

  • Non-accelerated filer
  • Smaller reporting company

Tectonic Therapeutic, Inc.

Sign in to watch
Ticker
TECX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
NY
Entity type
Operating
EIN
810710585
Phone
+1 339-666-3320
Business address
490 ARSENAL WAY, SUITE 200, WATERTOWN, MA
Former names
AvroBio, Inc., AVROBIO, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$13,920
in 2 filings, $14K under 10b5-1 plans

Net −$13,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. McNamara Peter −$14K Chief Scientific Officer sold 1% of stake
Date Insider Transaction Shares Price Value Owned after
2026-09-30 McNamara Peter Chief Scientific Officer Sale 10b5-1 −536 $23.04 $12K 54,305
2026-09-25 McNamara Peter Chief Scientific Officer Shares withheld for taxes 10b5-1 −444 $23.67 $11K 54,841
2026-09-03 McNamara Peter Chief Scientific Officer Grant or award · Employee Stock Option (Right to Buy) +21,000 21,000
2026-08-25 McNamara Peter Chief Scientific Officer Exercise or conversion 10b5-1 +43 $14.71 $633 55,328
2026-08-25 McNamara Peter Chief Scientific Officer Sale 10b5-1 −43 $36.52 $2K 55,285
2026-08-25 McNamara Peter Chief Scientific Officer Exercise or conversion · Employee Stock Option (Right to Buy) 10b5-1 −43 7,787
2026-08-12 McNamara Peter Chief Scientific Officer Exercise or conversion 10b5-1 +43 $14.71 $633 55,328
2026-08-12 McNamara Peter Chief Scientific Officer Sale 10b5-1 −43 $35.00 $2K 55,285
2026-08-12 McNamara Peter Chief Scientific Officer Exercise or conversion · Employee Stock Option (Right to Buy) 10b5-1 −43 7,830
2026-06-30 McNamara Peter Chief Scientific Officer Exercise or conversion 10b5-1 +172 $14.71 $3K 55,457
2026-06-30 McNamara Peter Chief Scientific Officer Sale 10b5-1 −172 $35.00 $6K 55,285
2026-06-30 McNamara Peter Chief Scientific Officer Exercise or conversion · Employee Stock Option (Right to Buy) 10b5-1 −172 7,873
2026-03-06 McNamara Peter Chief Scientific Officer Exercise or conversion 10b5-1 +2,500 $2.38 $6K 61,332
2026-03-06 McNamara Peter Chief Scientific Officer Exercise or conversion 10b5-1 +215 $14.71 $3K 61,547
2026-03-06 McNamara Peter Chief Scientific Officer Sale 10b5-1 −6,047 $30.00 $181K 55,500
2026-03-06 McNamara Peter Chief Scientific Officer Sale 10b5-1 −215 $35.00 $8K 55,285
2026-03-06 McNamara Peter Chief Scientific Officer Exercise or conversion · Employee Stock Option (Right to Buy) 10b5-1 −2,500 31,959
2026-03-06 McNamara Peter Chief Scientific Officer Exercise or conversion · Employee Stock Option (Right to Buy) 10b5-1 −215 8,045
2026-03-04 McNamara Peter Chief Scientific Officer Grant or award 10b5-1 +23,000 60,482
2026-03-04 McNamara Peter Chief Scientific Officer Sale 10b5-1 −1,650 $25.00 $41K 58,832

Page 1 of 2 · 36 trades